Researchers evaluated the effect of phosphodiesterase-5 inhibitor (PDE5I) initiation compared to non-use and Alzheimer’s disease development risk among males suffering from erectile dysfunction.
Study finds erectile dysfunction drugs linked to lower Alzheimer’s risk
- Post author:
- Post published:February 12, 2024
- Post category:uncategorized